- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Chase finalizes Unicorn deal, expands line
Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients.
Wilmington, DE-Chase Card Services, a division of JPMorgan Chase & Co., has finalized the acquisition of Unicorn Financial Services, a financing company for health-care patients. The combined company officially has launched its expanded set of patient financing products as ChaseHealthAdvance financing options.
Increasing medical and dental costs have created a need for new and adaptive health-care financing options, according to the company. In addition, the demand for elective procedures-dental, vision correction, and cosmetic, as well as veterinary care for pets-is increasing rapidly.
"Chase is able to offer affordable, flexible options for those looking to finance health-care procedures, as well as provide competitive service fees for providers," said Hugh Bleemer, general manager, ChaseHealthAdvance.
For more information on Chase-HealthAdvance financing options, visit http://www.chasehealthadvance.com/.
